During the past decade, Clinical Research Associates of Central PA conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 11 clinical trials were completed, i.e. on average, 55% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Associates of Central PA" #1 sponsor was "Indivior Inc." with 5 trials, followed by "Bellus Health Inc" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Kowa Research Institute, Inc." with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Associates of Central PA" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator, "Roswell Park Cancer Institute" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Associates of Central PA" are "Cardiovascular Disease" (3 trials), "Chronic Bronchitis" (2 trials), "Chronic Obstructive Pulmonary Disease" (2 trials), "Diabetes Mellitus, Type 2" (2 trials) and "Lung Cancer" (2 trials). Many other conditions were trialed in "Clinical Research Associates of Central PA" in a lesser frequency.

Most popular intervention types in "Clinical Research Associates of Central PA" are "Drug" (16 trials), "Device" (5 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "BLU-5937" (2 trials), "Fenofibrate" (2 trials), "K-877" (2 trials) and "Placebo (for K-877)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Associates of Central PA" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Research Associates of Central PA". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Clinical Research Associates of Central PA, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Associates of Central PA, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".